199 related articles for article (PubMed ID: 9050283)
21. A new type of perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease.
Rump JA; Schölmerich J; Gross V; Roth M; Helfesrieder R; Rautmann A; Lüdemann J; Gross WL; Peter HH
Immunobiology; 1990 Nov; 181(4-5):406-13. PubMed ID: 2099908
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
23. [Chronic inflammatory bowel disease and cardiovascular complications].
Rellecke P; Strauer BE
Med Klin (Munich); 2006 Mar; 101 Suppl 1():56-60. PubMed ID: 16802521
[TBL] [Abstract][Full Text] [Related]
24. Serum antibodies for the diagnosis of inflammatory bowel disease: ANCA for ulcerative colitis and ASCA for Crohn's disease.
Tecnologica MAP Suppl; 1999 Jun; ():18-20. PubMed ID: 10848041
[No Abstract] [Full Text] [Related]
25. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment.
Oudkerk Pool M; Ellerbroek PM; Ridwan BU; Goldschmeding R; von Blomberg BM; Peña AS; Dolman KM; Bril H; Dekker W; Nauta JJ
Gut; 1993 Jan; 34(1):46-50. PubMed ID: 8432451
[TBL] [Abstract][Full Text] [Related]
26. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
27. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype.
Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS
Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856
[TBL] [Abstract][Full Text] [Related]
28. Serologic markers in inflammatory bowel disease: state of the art.
Sandborn WJ
Rev Gastroenterol Disord; 2004; 4(4):167-74. PubMed ID: 15580151
[TBL] [Abstract][Full Text] [Related]
29. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease].
García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J
Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176
[TBL] [Abstract][Full Text] [Related]
30. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
[TBL] [Abstract][Full Text] [Related]
31. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
Mokrowiecka A; Gasiorowska A; Malecka-Panas E
Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
[TBL] [Abstract][Full Text] [Related]
32. [Anti-Saccharomyces cerevisiae antibodies in patients with Crohn's disease].
Barta Z; Csípö I; Antal-Szalmás P; Sipka S; Szabó G; Szegedi G
Orv Hetil; 2001 Oct; 142(42):2303-7. PubMed ID: 11760647
[TBL] [Abstract][Full Text] [Related]
33. Phagocytosis, killing, lymphocyte-mediated antibacterial activity, serum autoantibodies, and plasma endotoxins in inflammatory bowel disease.
Caradonna L; Amati L; Lella P; Jirillo E; Caccavo D
Am J Gastroenterol; 2000 Jun; 95(6):1495-502. PubMed ID: 10894586
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
36. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: clinical role and review of the literature.
Lombardi G; Annese V; Piepoli A; Bovio P; Latiano A; Napolitano G; Perri F; Conoscitore P; Andriulli A
Dis Colon Rectum; 2000 Jul; 43(7):999-1007. PubMed ID: 10910250
[TBL] [Abstract][Full Text] [Related]
37. Perinuclear antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies: serologic markers in inflammatory bowel disease.
Hartman C; Eliakim R; Shamir R
Isr Med Assoc J; 2004 Apr; 6(4):221-6. PubMed ID: 15115261
[No Abstract] [Full Text] [Related]
38. [Antineutrophil cytoplasmic antibodies (ANCA) in inflammatory diseases of the digestive tract].
Lamproye A; Belaiche J; Louis E; Salmon J; Mahieu P
Acta Gastroenterol Belg; 1994; 57(2):171-6. PubMed ID: 8053303
[TBL] [Abstract][Full Text] [Related]
39. p-ANCA target antigens in ulcerative colitis.
Folwaczny C; Jochum M; Noehl N; Schnettler D; Loeschke K; Fricke H
Z Gastroenterol; 1998 Aug; 36(8):625-33. PubMed ID: 9773480
[TBL] [Abstract][Full Text] [Related]
40. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
